Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder

Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University's Bouvé College of Health Sciences, is the Principal Investigator and Project...

Related Keywords

United States ,Elizabeth Byrnes ,Barbara Waszczak ,Markj Cooper ,Robertc Moen ,Centers For Disease ,Professor Of Pharmacology At Northeastern University Bouv ,National Institute On Drug Abuse ,Tufts Clinical Translational Science Institute ,National Institutes Of Health ,Affairs Of Copernicus ,Tufts University ,Brain Research Foundation ,College Of Health Sciences ,Northeastern University ,Copernicus Therapeutics Inc ,Health Sciences ,Principal Investigator ,Project Director ,Opioid Use ,National Institute ,Drug Abuse ,National Institutes ,Disease Control ,Principal Investigators ,Comparative Pathobiology ,Cummings School ,Veterinary Medicine ,Emmanuel Pothos ,Associate Professor ,Tufts University School ,Medical Affairs ,Copernicus Therapeutics ,Tufts Clinical Translational Science ,More Information ,